LinguaFlex Tongue Retractor (LTR) for the Treatment of OSA and Snoring in Adults
Part of paid clinical trials in Brighton, Massachusetts.
- Sponsor
- Linguaflex, Inc.
- Study ID
- NCT04129229
- Status
- Enrolling By Invitation
Conditions
- Obstructive Sleep Apnea
- Snoring
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- LinguaFlex Tongue Retractor (LTR) — DEVICEThe LinguaFlex Tongue Retractor (LTR) is a small, flexible, implanted tongue retaining device that lessens the backward movement of the tongue during sleep. The LTR's flexible shaft and a nubbed tether passes through the center of the tongue beneath the tongue blade (frenulum area) and connects to a disc (head) that rests on the external surface of the tongue base mucosa. Underneath the tongue, on the external surface of the frenulum, a small anchor secures the shaft that can be adjusted to tension the LTR to maximize therapeutic effect and maintain comfort.
Study Details
The LinguaFlex™ Tongue Retractor (LTR) is an investigational medical device that is inserted into the tongue to lessen its backward movement during sleep. This helps to keep the airway open during sleep so that the tongue doesn't block the airway causing obstructive apnea or narrow it enough to cause snoring. This study will monitor the effectiveness of the LTR device in the reduction of Obstructive Sleep Apnea and snoring over the course of a one-year treatment period.
Key Dates
- Start date
- Jan 10, 2020
- Status verified
- Oct 2024
- Primary completion
- Dec 31, 2025
- Completion
- Apr 30, 2026
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: LTR TreatmentEligible subjects will undergo insertion of the LTR device in their tongue. Initiation of treatment will occur 7 days post insertion procedure and will be monitored over the course of 1 year.
Primary Outcome Measure
Responder to Therapy [ Time Frame: One Year ]
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| St. Elizabeth's Medical Center | Brighton | Massachusetts | 02135 | - |
| WVU Medicine / J. W. Ruby Memorial Hospital | Morgantown | West Virginia | 26505 | - |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | - |
Find similar trials in Brighton, MA
Related Studies
- Pharmacological Activation of HMN for OSA Aim 2PHASE1/PHASE2 · Recruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Prevalence and Impact of Obstructive Sleep Apnea in Multiple SclerosisRecruiting · Beth Israel Deaconess Medical Center · Boston, Massachusetts
- Rescue Pharmacotherapy for OSAPHASE1/PHASE2 · Recruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Atomoxetine and DAW2022 on OSA SeverityPHASE1/PHASE2 · Recruiting · Brigham and Women's Hospital · Boston, Massachusetts